New drug duo tested in fight against tough head & neck cancers
NCT ID NCT05252429
Summary
This study is testing if combining two existing cancer drugs, docetaxel and pembrolizumab, is a safe and effective treatment for people with advanced head and neck cancer that has come back or spread. It aims to see if this combination can help shrink tumors and help patients live longer. The trial is for adults who have not yet received treatment for their advanced cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EFFECT OF DRUG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hokkaido University Hospital
Sapporo, Hokkaido, 0608648, Japan
Conditions
Explore the condition pages connected to this study.